blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2831104

EP2831104 - BIOMARKERS FOR USE IN INTEGRIN THERAPY APPLICATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.02.2022
Database last updated on 18.01.2025
FormerThe patent has been granted
Status updated on  19.03.2021
FormerGrant of patent is intended
Status updated on  13.02.2020
FormerExamination is in progress
Status updated on  08.01.2020
FormerGrant of patent is intended
Status updated on  03.09.2019
FormerExamination is in progress
Status updated on  03.03.2017
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Biogen MA Inc.
225 Binney Street
Cambridge, MA 02142 / US
For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
[2020/07]
Former [2015/28]For all designated states
Biogen MA Inc.
250 Binney Street
Cambridge, MA 02142 / US
For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
Former [2015/06]For all designated states
Biogen Idec MA Inc.
14 Cambridge Center
Cambridge, MA 02142 / US
For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
Inventor(s)01 / VIOLETTE, Shelia M.
91 Simonds Road
Lexington, Massachusetts 02420 / US
02 / SHEPPARD, Dean
1006 Hubert Road
Oakland, California 94610 / US
 [2015/06]
Representative(s)Pohlman, Sandra M.
df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Theatinerstrasse 16
80333 München / DE
[2015/06]
Application number, filing date13768248.015.03.2013
[2021/16]
WO2013US32082
Priority number, dateUS201261617451P29.03.2012         Original published format: US 201261617451 P
US201261648199P17.05.2012         Original published format: US 201261648199 P
[2015/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013148316
Date:03.10.2013
Language:EN
[2013/40]
Type: A1 Application with search report 
No.:EP2831104
Date:04.02.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 03.10.2013 takes the place of the publication of the European patent application.
[2015/06]
Type: B1 Patent specification 
No.:EP2831104
Date:21.04.2021
Language:EN
[2021/16]
Search report(s)International search report - published on:US03.10.2013
(Supplementary) European search report - dispatched on:EP19.08.2015
ClassificationIPC:C07K14/495, G01N33/68
[2015/38]
CPC:
C12Q1/6883 (EP,US); C12Q1/6876 (US); G01N33/6893 (EP,US);
C12Q2600/106 (EP,US); C12Q2600/158 (EP,US); G01N2333/495 (EP,US);
G01N2333/70546 (EP,US); G01N2800/52 (EP,US) (-)
Former IPC [2015/06]C07K14/495
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/06]
Extension statesBA22.10.2014
ME22.10.2014
TitleGerman:BIOMARKER ZUR VERWENDUNG IN INTEGRINTHERAPIEANWENDUNGEN[2015/06]
English:BIOMARKERS FOR USE IN INTEGRIN THERAPY APPLICATIONS[2015/06]
French:BIOMARQUEURS UTILISABLES DANS DES APPLICATIONS DE TRAITEMENT PAR L'INTÉGRINE[2015/06]
Entry into regional phase22.10.2014National basic fee paid 
22.10.2014Search fee paid 
22.10.2014Designation fee(s) paid 
22.10.2014Examination fee paid 
Examination procedure22.10.2014Examination requested  [2015/06]
04.03.2016Amendment by applicant (claims and/or description)
07.03.2017Despatch of a communication from the examining division (Time limit: M04)
07.07.2017Reply to a communication from the examining division
09.03.2018Despatch of a communication from the examining division (Time limit: M04)
06.07.2018Reply to a communication from the examining division
04.09.2019Communication of intention to grant the patent
02.01.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
14.02.2020Communication of intention to grant the patent
22.09.2020Fee for grant paid
22.09.2020Fee for publishing/printing paid
22.09.2020Receipt of the translation of the claim(s)
22.10.2020Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.03.2017
Opposition(s)24.01.2022No opposition filed within time limit [2022/13]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
22.09.2020Request for further processing filed
22.09.2020Full payment received (date of receipt of payment)
Request granted
01.10.2020Decision despatched
Fees paidRenewal fee
27.03.2015Renewal fee patent year 03
31.03.2016Renewal fee patent year 04
27.03.2017Renewal fee patent year 05
12.03.2018Renewal fee patent year 06
29.03.2019Renewal fee patent year 07
21.12.2020Renewal fee patent year 08
12.03.2021Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
31.03.202008   M06   Fee paid on   21.12.2020
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.03.2013
AL21.04.2021
AT21.04.2021
CY21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
MK21.04.2021
MT21.04.2021
NL21.04.2021
PL21.04.2021
RO21.04.2021
RS21.04.2021
SE21.04.2021
SI21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
[2024/41]
Former [2024/22]HU15.03.2013
AL21.04.2021
AT21.04.2021
CY21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
MK21.04.2021
NL21.04.2021
PL21.04.2021
RO21.04.2021
RS21.04.2021
SE21.04.2021
SI21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
Former [2024/20]HU15.03.2013
AL21.04.2021
AT21.04.2021
CY21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
NL21.04.2021
PL21.04.2021
RO21.04.2021
RS21.04.2021
SE21.04.2021
SI21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
Former [2024/18]HU15.03.2013
AL21.04.2021
AT21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
NL21.04.2021
PL21.04.2021
RO21.04.2021
RS21.04.2021
SE21.04.2021
SI21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
Former [2022/47]AL21.04.2021
AT21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
NL21.04.2021
PL21.04.2021
RO21.04.2021
RS21.04.2021
SE21.04.2021
SI21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
Former [2022/29]AL21.04.2021
AT21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
NL21.04.2021
PL21.04.2021
RO21.04.2021
RS21.04.2021
SE21.04.2021
SI21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
Former [2022/26]AL21.04.2021
AT21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
NL21.04.2021
PL21.04.2021
RO21.04.2021
RS21.04.2021
SE21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
Former [2022/23]AT21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
NL21.04.2021
PL21.04.2021
RO21.04.2021
RS21.04.2021
SE21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
Former [2022/10]AT21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
NL21.04.2021
PL21.04.2021
RO21.04.2021
RS21.04.2021
SE21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
PT23.08.2021
IS22.12.2021
Former [2022/09]AT21.04.2021
CZ21.04.2021
DK21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
NL21.04.2021
PL21.04.2021
RO21.04.2021
RS21.04.2021
SE21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
Former [2022/08]AT21.04.2021
CZ21.04.2021
DK21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
NL21.04.2021
PL21.04.2021
RS21.04.2021
SE21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
Former [2022/07]AT21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
NL21.04.2021
PL21.04.2021
RS21.04.2021
SE21.04.2021
SM21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
Former [2021/52]AT21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
NL21.04.2021
PL21.04.2021
RS21.04.2021
SE21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
Former [2021/51]AT21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
NL21.04.2021
RS21.04.2021
SE21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
IS21.08.2021
PT23.08.2021
Former [2021/50]AT21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
NL21.04.2021
SE21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
PT23.08.2021
Former [2021/49]AT21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
NL21.04.2021
SE21.04.2021
BG21.07.2021
NO21.07.2021
GR22.07.2021
Former [2021/47]AT21.04.2021
FI21.04.2021
LT21.04.2021
NL21.04.2021
BG21.07.2021
Former [2021/46]AT21.04.2021
FI21.04.2021
LT21.04.2021
Documents cited:Search[A]WO2005039547  (MERCK PATENT GMBH [DE], et al) [A] 1-20 * the whole document *;
 [A]WO2008147434  (UNIV CALIFORNIA [US], et al) [A] 1-20 * the whole document *;
 [A]WO2010072348  (MERCK PATENT GMBH [DE], et al) [A] 1-20* the whole document *
International search[Y]WO03097615  (SCIOS INC [US], et al);
 [Y]WO2005044794  (BAYER PHARMACEUTICALS CORP [US], et al);
 [Y]WO2008008315  (BIOGEN IDEC INC [US], et al);
 [Y]WO2009103542  (MUBIO PRODUCTS BV [NL], et al);
 [Y]US2011305629  (VIOLETTE SHELIA M [US], et al);
 [Y]WO2012031008  (GEN HOSPITAL CORP [US], et al);
 [Y]  - XU ET AL., "Lysophosphatidic Acid Induces avB6 ntegrin-Mediated TGF-B Activation via the LPA2 Receptor and the Small G Protein Gaq.", AMERICAN JOURNAL OF PATHOLOGY, (200904), vol. 174, pages 1264 - 1279, XP055169217

DOI:   http://dx.doi.org/10.2353/ajpath.2009.080160
by applicantWO2008008315
 US2011305629
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.